17:00 - 18:48
Bio-O2
Biologic Insights | Oral presentations 2
Chair/s:
Maarten Vermeer, Richard Andrew Cowan, Emmanuella Guenova
17:00 - 17:12
Bio-O2-01
Mass cytometry and machine learning delineate tumor-defining cells in Sézary syndrome to allow discrimination from benign erythroderma
Oral presentation
Yi-Chien Tsai
(Department of Dermatology, Lausanne University Hospital (CHUV) and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland)
 
17:12 - 17:24
Bio-O2-02
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome
Oral presentation
Safa Najidh
(Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands)
 
17:24 - 17:36
Bio-O2-03
Quantifying response to various treatments using the revisited blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker
Oral presentation
Gabor Dobos
(Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France | UMR-976, HIPI (Immunologie humaine, Pathophysiologie, Immunothérapie), INSERM, Paris, France | Department of Dermatology, Venerology and Allergology, Charité-Universtaetsmedizin Berlin, Berlin, Germany)
 
17:36 - 17:48
Bio-O2-04
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
Oral presentation
Christoph Iselin
(Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland)
 
17:48 - 18:00
Bio-O2-05
Epigenetic modifiers can alter telomerase expression and clonogenic capacities of Sézary cells
Oral presentation
Edith Chevret
(Univ. Bordeaux, INSERM, BaRITOn, U1053, Bordeaux, France)
 
18:00 - 18:12
Bio-O2-06
Mechanisms of Resistance to Anti-CCR4 Antibody, Mogamulizumab, in Cutaneous T cell Lymphoma
Oral presentation
Sara Beygi
(Stanford University, Stanford, CA, United States)
18:12 - 18:24
Bio-O2-07
Primary Cytotoxic T Cell Lymphomas Harbor Recurrent Targetable Alterations in the JAK-STAT Pathway
Oral presentation
Katie Lee
(Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States | Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States)
18:24 - 18:36
Bio-O2-08
Mutational landscape of Nodal Peripheral T-cell lymphoma subtypes
Oral presentation
Laura Tomas-Roca
(Instituto de Investigación Fundación Jiménez Díaz, Madrid, Spain)
 
18:36 - 18:48
Bio-O2-09
Clues for disease progression at time of diagnosis in patients with primary cutaneous follicle center lymphoma
Oral presentation
Anne M.R. Schrader
(Leiden University Medical Center, Leiden, Netherlands)